Crinetics Pharmaceuticals, Inc. , a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors.
Crinetics Pharmaceuticals stock last closed at $56.69, up 1.3% from the previous day, and has increased 91.84% in one year. It has overperformed other stocks in the Biotechnology industry by 0.87 percentage points. Crinetics Pharmaceuticals stock is currently +120.16% from its 52-week low of $25.75, and -5.58% from its 52-week high of $60.04.
At the moment, there are 80.04M CRNX shares outstanding. The market value of CRNX is $4.54B. In the past 24 hours, 356,956 CRNX shares were traded.
How to Buy Crinetics Pharmaceuticals Stock
Not sure how to invest in Crinetics Pharmaceuticals stock? Here's how.
Figure out where to buy Crinetics Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Crinetics Pharmaceuticals stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit funds into your investment account: Pick your payment method and add your information.
Evaluate Crinetics Pharmaceuticals stock: The Crinetics Pharmaceuticals ticker symbol is CRNX. Is Crinetics Pharmaceuticals stock a good investment? Should you buy shares of CRNX? How do CRNX's underlying business fundamentals look? Do top analysts think Crinetics Pharmaceuticals is a good buy? Why has CRNX's stock price moved recently? (Hint: Our stock market research tools can help you figure out if CRNX is a good stock to buy).
Make your CRNX buy order: Decide if you will purchase CRNX shares at the current market price or use a limit order to purchase CRNX stock at a specific price.
Get the latest news on your CRNX position: Create a watchlist to keep track of your investment in Crinetics Pharmaceuticals stock.
Step 1: Figure out where to buy Crinetics Pharmaceuticals stock
You will need an online brokerage account in order to access the NASDAQ market and buy CRNX shares.
A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world financial markets: From Technology to Industrials, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've selected your brokerage, you need to fill out some personal details so you can buy CRNX today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Crinetics Pharmaceuticals stock
Once you have decided on the best place to buy Crinetics Pharmaceuticals stock, it's very important to evaluate their stock before you invest, so you truly comprehend the risk as well as the opportunity.
Crinetics Pharmaceuticals shares quick numbers
CRNX Price
$56.69
1w %
-2.19%
1y %
91.84%
5y %
204.95%
P/E
-15.08x
P/B
5.46x
P/S
3,149.44x
PEG
N/A
Revenue
$1.39M
Earnings
-$258.54M
Fore. Rev. Growth
226.71%
Fore. Earn. Growth
N/A
Market Cap
$4.54B
Next Earnings
Nov 12, 2024
Next Dividend
N/A
Crinetics Pharmaceuticals Fundamentals
WallStreetZen was designed to help average investors do better fundamental analysis in less time.
CRNX has cash burn of 185049000. It has sufficient cash and short-term investments to cover this for at least one year.
There are more short-term assets than long-term liabilities on the CRNX balance sheet.
There are more short-term assets than short-term liabilities on the CRNX balance sheet.
CRNX has $864.25M in cash and short term investments. This is sufficient to cover its annual cash burn of $185.05M.
Negative Financial Indicators:
CRNX profit margin has gone down from -3,804.1% to -18,667.1% in the past year.
Total CRNX debt is higher than 5 years ago, relative to shareholder equity.
Do analysts think it's a good time to buy CRNX stock
Out of 8 Equities analysts who track CRNX, the consensus analyst rating on Crinetics Pharmaceuticals is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Latest CRNX Analyst Recommendations
Yasmeen Rahimi, a top 3% analyst from Piper Sandler maintains CRNX with a strong buy rating and maintains their CRNX price target from $97.00 to $97.00, on Jul 2, 2024.
Brian Skorney, a top 17% analyst from Baird maintains CRNX with a buy rating and raises their CRNX price target from $52.00 to $62.00, on May 23, 2024.
Jeffrey Hung, a top 12% analyst from Morgan Stanley maintains CRNX with a strong buy rating and raises their CRNX price target from $50.00 to $70.00, on May 23, 2024.
Last year, CRNX revenue was $1.39M. During the last 5 year, CRNX's revenue has increased by -3.97% per year. This was slower than the Biotechnology industry average of 63.28%.
No, Crinetics Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about CRNX
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your CRNX buy order
There are two primary order types:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are mostly fine for most investors.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a particular dollar amount limit, place a limit order.
Hit the Open button and your broker will place your order.
If you want additional assistance investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Crinetics Pharmaceuticals share?
As of Nov 1, 2024, it costs $56.69 to buy one share of Crinetics Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.176 shares of CRNX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.